These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9272758)

  • 1. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects.
    Röschke J; Kögel P; Schlösser R; Wagner P; Mann K; Rossbach W; Benkert O
    Psychopharmacology (Berl); 1997 Jul; 132(1):44-9. PubMed ID: 9272758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers.
    Schlösser R; Röschke J; Rossbach W; Benkert O
    Eur Neuropsychopharmacol; 1998 Dec; 8(4):273-8. PubMed ID: 9928916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
    Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.
    Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J
    Sleep; 1995 Jul; 18(6):470-7. PubMed ID: 7481419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
    Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
    Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men.
    Wilson S; Højer AM; Buchberg J; Areberg J; Nutt DJ
    J Psychopharmacol; 2015 Oct; 29(10):1085-91. PubMed ID: 26253622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.
    Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ
    Eur Neuropsychopharmacol; 2004 Oct; 14(5):367-72. PubMed ID: 15336297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers.
    Schlösser R; Wetzel H; Dörr H; Rossbach W; Hiemke C; Benkert O
    Psychoneuroendocrinology; 2000 May; 25(4):377-88. PubMed ID: 10725614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C; Wilson S; Rich A; Bailey J; Nutt D
    Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
    Feige B; Voderholzer U; Riemann D; Dittmann R; Hohagen F; Berger M
    Neuropsychopharmacology; 2002 Feb; 26(2):246-58. PubMed ID: 11790520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.
    Murck H; Nickel T; Künzel H; Antonijevic IA; Schill J; Zobel A; Steiger A; Sonntag A; Holsboer F
    Neuropsychopharmacology; 2003 Feb; 28(2):348-58. PubMed ID: 12589388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men.
    Murck H; Frieboes RM; Antonijevic IA; Steiger A
    Psychopharmacology (Berl); 2001 May; 155(2):187-92. PubMed ID: 11401008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
    J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea.
    Kraiczi H; Hedner J; Dahlöf P; Ejnell H; Carlson J
    Sleep; 1999 Feb; 22(1):61-7. PubMed ID: 9989366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.
    Smith MI; Piper DC; Duxon MS; Upton N
    Pharmacol Biochem Behav; 2002 Apr; 71(4):599-605. PubMed ID: 11888551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea.
    Berry RB; Yamaura EM; Gill K; Reist C
    Sleep; 1999 Dec; 22(8):1087-92. PubMed ID: 10617169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.